E-Prescribing Market

Market Overview:

The global e-prescribing market size reached US$ 1.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.1 Million by 2028, exhibiting a growth rate (CAGR) of 22.1% during 2023-2028. The increasing adoption of digital healthcare solutions, the rising focus on reducing medication errors, improving patient safety, and streamlining prescription workflows, and the integration of e-prescribing systems with electronic health records are some of the factors propelling the market.

E-prescribing is a modern method of generating and transmitting prescription orders between healthcare providers and pharmacies using a secure digital platform. Its development was driven by the need to enhance the prescription process, replacing traditional handwritten prescriptions with a more efficient and error-reducing approach. The advantages of e-prescribing are manifold, such as it minimizes the risk of medication errors caused by illegible handwriting, leading to improved patient safety. It also streamlines the prescription workflow, enabling real-time access to patient medication history and drug interactions and promoting better-informed decisions by healthcare professionals. Additionally, e-prescribing enhances medication adherence through automatic refill reminders and patient education.

The global e-prescribing market is influenced by the increasing emphasis on reducing medication errors and improving patient safety. E-prescribing systems help minimize errors related to prescription legibility, dosage, and drug interactions, thereby enhancing patient outcomes. Moreover, the rising adoption of healthcare information technology and electronic health records (EHRs) is boosting the market growth. Integrating e-prescribing solutions with EHRs streamlines the prescription process and promotes interoperability. Additionally, government initiatives promoting the adoption of e-prescribing systems, the growing burden of chronic diseases, and the need for efficient prescription management are fostering the market growth.

E-Prescribing Market Trends/Drivers:

Patient safety and medication error reduction

One of the primary drivers of the global e-prescribing market is the pressing need to enhance patient safety and minimize medication errors. Traditional paper-based prescriptions are susceptible to errors, including illegible handwriting and incorrect dosages, which can lead to adverse drug events and compromised patient well-being. E-prescribing systems address these issues by providing clear, electronically generated prescriptions that can be easily interpreted by pharmacists and healthcare providers. Through built-in checks for drug interactions and allergies, these systems help prevent potentially harmful medication combinations. By improving prescription accuracy and reducing errors, e-prescribing contributes significantly to improving patient outcomes and overall healthcare quality.

Adoption of healthcare information technology and EHRs

The increasing adoption of healthcare information technology, including electronic health records (EHRs), is another crucial driver for the e-prescribing market. EHRs serve as comprehensive electronic databases that store patient health information, medical history, and prescriptions. Integrating e-prescribing systems with EHRs streamlines the prescription process, enabling healthcare providers to access patients' medication records and make informed decisions. This interoperability enhances communication between physicians, pharmacists, and patients, leading to better-coordinated care. The seamless exchange of prescription information also reduces the risk of duplicate prescriptions and helps healthcare professionals make well-informed decisions regarding medication management.

Government initiatives promoting the adoption of e-prescribing systems 

Governments worldwide have recognized the potential benefits of e-prescribing in improving healthcare efficiency and reducing healthcare costs. As a result, they have implemented various initiatives and mandates to promote the adoption of e-prescribing systems. These initiatives often come in the form of financial incentives, penalties, or requirements for healthcare providers to adopt digital prescription methods. By encouraging the transition from paper-based prescriptions to electronic systems, governments aim to standardize and streamline the prescription process, ultimately improving patient care. The endorsement from regulatory bodies and policymakers provides credibility to e-prescribing solutions, driving their wider acceptance and integration within healthcare settings, further boosting the growth of the global e-prescribing market. 

E-Prescribing Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global e-prescribing market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on component, delivery mode, end user and specialties.

Breakup by Component:

• Solutions
• Services
   

Solutions dominate the market

The report has provided a detailed breakup and analysis of the market based on the component. This includes solutions and services. According to the report, solutions represented the largest segment.

The solutions segment dominates the global e-prescribing market due to the increasing focus on patient safety and reducing medication errors. These solutions offer features like drug interaction checks, allergy alerts, and dosage recommendations, ensuring accurate and safe prescriptions, ultimately improving patient outcomes. Moreover, the rising adoption of EHRs and healthcare information technology has driven the demand for integrated e-prescribing solutions. The seamless integration of e-prescribing with EHRs streamlines the prescription process, facilitating efficient communication between healthcare providers and pharmacists. Furthermore, government initiatives and mandates promoting the use of e-prescribing systems have significantly contributed to the dominance of the segment.

Breakup by Delivery Mode:

• Web-Based
• Cloud-Based
• On-Premises
   

Web-Based holds the largest share in the market

A detailed breakup and analysis of the market based on the delivery mode has also been provided in the report. This includes web-based, cloud-based, and on-premises. According to the report, web-based represented the largest segment.

The web-based segment dominates the e-prescribing market due to several key market drivers. Web-based solutions offer accessibility and convenience, allowing healthcare providers to access the system from any location with an internet connection. Additionally, these solutions typically require minimal hardware and software installations, reducing implementation costs and complexity. Moreover, web-based e-prescribing systems often integrate seamlessly with EHRs, promoting interoperability and enhancing prescription management. Furthermore, the rising adoption of telehealth and digital healthcare solutions further propels the demand for web-based e-prescribing. These factors collectively drive the web-based segment's dominance in the e-prescribing market, catering to the growing need for efficient and user-friendly prescription management solutions.

Breakup by End User:

• Hospitals
• Pharmacies
• Office-Based Physicians
• Others
   

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, pharmacies, office-based physicians, and others. According to the report, hospitals represented the largest segment.

The hospital segment dominates the e-prescribing market due to several key market drivers. Hospitals handle a large volume of patients and prescriptions, making the adoption of e-prescribing systems highly beneficial in streamlining prescription processes and reducing medication errors. Additionally, hospitals often have advanced healthcare information technology infrastructure, enabling seamless integration of e-prescribing solutions with EHRs for efficient prescription management. Furthermore, government initiatives and mandates promoting the use of e-prescribing in healthcare facilities, including hospitals, have further accelerated the adoption of these systems.

Breakup by Specialties:

• Oncology
• Sports Medicine
• Neurology
• Cardiology
• Others
   

Oncology holds the largest share in the market

A detailed breakup and analysis of the market based on specialties has also been provided in the report. This includes oncology, sports medicine, neurology, cardiology, and others. According to the report, oncology accounted for the largest market share.

The oncology segment dominates the e-prescribing market due to the increasing prevalence of cancer cases worldwide, which has led to a higher demand for efficient and streamlined prescription management. Moreover, oncology treatments often involve complex medication regimens, making e-prescribing systems crucial for reducing errors and ensuring precise drug administration. In confluence with this, advancements in cancer research and personalized medicine have led to a wider range of targeted therapies, necessitating sophisticated e-prescribing tools to handle specialized prescriptions. Furthermore, government initiatives and healthcare policies promoting electronic prescriptions in oncology contributes to the segment's dominance.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America exhibits a clear dominance, accounting for the largest e-prescribing market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America dominates the e-prescribing market due to several key market drivers. The region has a highly developed healthcare infrastructure and a strong focus on technological advancements, which creates a favorable environment for the adoption of e-prescribing systems. Additionally, the presence of government initiatives and regulations promoting the use of electronic health records and e-prescribing solutions further accelerates the market growth. These initiatives aim to improve patient safety, reduce medication errors, and enhance overall healthcare efficiency. Moreover, a well-established pharmaceutical industry and a large patient population with chronic diseases drive the demand for streamlined prescription processes. Furthermore, North America has a high level of healthcare spending, allowing healthcare organizations to invest in innovative technologies like e-prescribing.

Competitive Landscape:

The competitive landscape of the global e-prescribing market is characterized by intense competition among key players striving to establish themselves as leaders in this rapidly evolving industry. Major healthcare technology companies, EHR vendors, and specialized e-prescribing solution providers vie for market share. Established players leverage their extensive customer base and experience in the healthcare sector to offer comprehensive and integrated e-prescribing solutions. Simultaneously, new entrants and startups focus on innovation, aiming to introduce disruptive technologies that cater to specific niche requirements.

To gain a competitive edge, companies emphasize enhancing the usability and interoperability of their e-prescribing platforms. Moreover, they focus on compliance with stringent regulatory standards to ensure data security and patient privacy. Additionally, strategic partnerships and collaborations with healthcare organizations and pharmacies enable companies to expand their reach and customer base. With the ever-increasing demand for streamlined prescription processes and patient safety, competition is expected to intensify further, leading to ongoing advancements and improvements in e-prescribing solutions worldwide.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Allscripts Healthcare Solutions Inc.
• Athenahealth Inc. (Veritas Capital and Evergreen Coast Capital)
• Cerner Corporation
• Computer Programs and Systems Inc.
• DrFirst.com Inc.
• Epic Systems Corporation
• Henry Schein Inc.
• Medical Information Technology Inc.
• Nextgen Healthcare Inc.
• Surescripts LLC.

Recent Developments:

• In June, 2023 – CPSI announced the expansion of its four-year partnership with MidCoast Health System. The expansion includes a 25-bed critical access hospital (CAH) located in Crockett, Texas and the implementation of CPSI’s EHR, accounts receivables services and IT managed services at Crockett Medical Center.
• In February, 2023, Oracle Cerner announced that it has been awarded the 2022 Best in KLAS Acute Care EMR for Middle East and Africa, proving its stance as a global leader in healthcare technology.
• In January, 2023, Allscripts Healthcare Solutions announced that the company will now be called Veradigm.

E-Prescribing Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the e-prescribing market from 2017-2028.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global e-prescribing market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the e-prescribing industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.